Search
Menu
Bristol Instruments, Inc. - 872 Series High-Res 4/24 LB

TriPath Imaging Inc.

Facebook X LinkedIn Email
TriPath Imaging Inc. of Burlington, N.C., has received the FDA’s 510(k) approval to use the Ki-67 cell proliferation biomarker with the Ventana Image Analysis System from Ventana Medical Systems Inc. of Tucson, Ariz. The biomarker enables pathologists to determine the percentage of tumor cells that are actively dividing with precise quantitative measurements of the biomarker’s expression in breast biopsy samples. The approach is expected to aid scientists in further investigations into the correlation between proliferation rate and survival.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: June 2006
    BiophotonicsBusinessRapidScan

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.